IL86824A - Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin
- Google Patents
Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin
Info
Publication number
IL86824A
IL86824AIL8682488AIL8682488AIL86824AIL 86824 AIL86824 AIL 86824AIL 8682488 AIL8682488 AIL 8682488AIL 8682488 AIL8682488 AIL 8682488AIL 86824 AIL86824 AIL 86824A
Authority
IL
Israel
Prior art keywords
iododoxorubicin
deoxy
dihydro
antitumor agent
agent obtained
Prior art date
Application number
IL8682488A
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo SpafiledCriticalErba Carlo Spa
Priority to IL8682488ApriorityCriticalpatent/IL86824A/en
Priority claimed from AU18682/88Aexternal-prioritypatent/AU601857B2/en
Publication of IL86824ApublicationCriticalpatent/IL86824A/en
IL8682488A1988-06-211988-06-21Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin
IL86824A
(en)
Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin